Literature DB >> 19369211

PALB2 is an integral component of the BRCA complex required for homologous recombination repair.

Shirley M H Sy1, Michael S Y Huen, Junjie Chen.   

Abstract

Mutations in breast cancer susceptibility gene 1 and 2 (BRCA1 and BRCA2) predispose individuals to breast and ovarian cancer development. We previously reported an in vivo interaction between BRCA1 and BRCA2. However, the biological significance of their association is thus far undefined. Here, we report that PALB2, the partner and localizer of BRCA2, binds directly to BRCA1, and serves as the molecular scaffold in the formation of the BRCA1-PALB2-BRCA2 complex. The association between BRCA1 and PALB2 is primarily mediated via apolar bonding between their respective coiled-coil domains. More importantly, BRCA1 mutations identified in cancer patients disrupted the specific interaction between BRCA1 and PALB2. Consistent with the converging functions of the BRCA proteins in DNA repair, cells harboring mutations with abrogated BRCA1-PALB2 interaction resulted in defective homologous recombination (HR) repair. We propose that, via its direct interaction with PALB2, BRCA1 fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Our findings uncover PALB2 as the molecular adaptor between the BRCA proteins, and suggest that impaired HR repair is one of the fundamental causes for genomic instability and tumorigenesis observed in patients carrying BRCA1, BRCA2, or PALB2 mutations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369211      PMCID: PMC2678481          DOI: 10.1073/pnas.0811159106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  New complexities for BRCA1 and BRCA2.

Authors:  P Kerr; A Ashworth
Journal:  Curr Biol       Date:  2001-08-21       Impact factor: 10.834

2.  Predicting coiled coils from protein sequences.

Authors:  A Lupas; M Van Dyke; J Stock
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

3.  DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains.

Authors:  Xiaochun Yu; Junjie Chen
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

4.  Brca1 controls homology-directed DNA repair.

Authors:  M E Moynahan; J W Chiu; B H Koller; M Jasin
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

5.  Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation.

Authors:  M E Moynahan; T Y Cui; M Jasin
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

6.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

Review 7.  Emerging functions of BRCA2 in DNA recombination.

Authors:  Luca Pellegrini; Ashok Venkitaraman
Journal:  Trends Biochem Sci       Date:  2004-06       Impact factor: 13.807

8.  The BRCT domain is a phospho-protein binding domain.

Authors:  Xiaochun Yu; Claudia Christiano Silva Chini; Miao He; Georges Mer; Junjie Chen
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

9.  Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair.

Authors:  Junran Zhang; Henning Willers; Zhihui Feng; Jagadish C Ghosh; Sang Kim; David T Weaver; Jay H Chung; Simon N Powell; Fen Xia
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 10.  Functions of BRCA1 and BRCA2 in the biological response to DNA damage.

Authors:  A R Venkitaraman
Journal:  J Cell Sci       Date:  2001-10       Impact factor: 5.285

View more
  252 in total

1.  ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair.

Authors:  Jean-Yves Bleuyard; Rémi Buisson; Jean-Yves Masson; Fumiko Esashi
Journal:  EMBO Rep       Date:  2012-02-01       Impact factor: 8.807

Review 2.  BRCA1-directed, enhanced and aberrant homologous recombination: mechanism and potential treatment strategies.

Authors:  Seth M Dever; E Railey White; Matthew C T Hartman; Kristoffer Valerie
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

Review 3.  The Fanconi anemia pathway and DNA interstrand cross-link repair.

Authors:  Xiaoyu Su; Jun Huang
Journal:  Protein Cell       Date:  2011-09-23       Impact factor: 14.870

4.  The ups and downs of DNA repair biomarkers for PARP inhibitor therapies.

Authors:  Xiaozhe Wang; David T Weaver
Journal:  Am J Cancer Res       Date:  2010-01-03       Impact factor: 6.166

Review 5.  Poly (ADP-ribose) polymerase inhibitors: on the horizon of tailored and personalized therapies for epithelial ovarian cancer.

Authors:  Elena S Ratner; Alan C Sartorelli; Z Ping Lin
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.645

6.  MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks.

Authors:  Tomohiro Hayakawa; Fan Zhang; Noriyo Hayakawa; Yasuko Ohtani; Kaori Shinmyozu; Jun-ichi Nakayama; Paul R Andreassen
Journal:  J Cell Sci       Date:  2010-04-01       Impact factor: 5.285

Review 7.  Functional assays for analysis of variants of uncertain significance in BRCA2.

Authors:  Lucia Guidugli; Aura Carreira; Sandrine M Caputo; Asa Ehlen; Alvaro Galli; Alvaro N A Monteiro; Susan L Neuhausen; Thomas V O Hansen; Fergus J Couch; Maaike P G Vreeswijk
Journal:  Hum Mutat       Date:  2013-12-03       Impact factor: 4.878

Review 8.  Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice.

Authors:  Arun Gupta; Clayton R Hunt; Sharmistha Chakraborty; Raj K Pandita; John Yordy; Deepti B Ramnarain; Nobuo Horikoshi; Tej K Pandita
Journal:  Radiat Res       Date:  2013-12-09       Impact factor: 2.841

9.  MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination.

Authors:  Fan Zhang; Gregory Bick; Jung-Young Park; Paul R Andreassen
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

Review 10.  BRCA1 Mutation: A Predictive Marker for Radiation Therapy?

Authors:  Charlene Kan; Junran Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.